WHO updates its guidance on treatments for COVID-19
WHO recommends the use of antiviral drug nirmatrelvir-ritonavir in patients with non-severe COVID-19 at high and moderate risk of hospital admission. The World Health Organization (WHO) has updated its guidance on treatments for patients with COVID-19, providing latest, trustworthy advice on the management of the disease to help doctors make better decisions. Key Points
The Tribune IndiaWHO updates its guidance on treatments for COVID-19
WHO recommends the use of antiviral drug nirmatrelvir-ritonavir in patients with non-severe COVID-19 at high and moderate risk of hospital admission. The World Health Organization (WHO) has updated its guidance on treatments for patients with COVID-19, providing latest, trustworthy advice on the management of the disease to help doctors make better decisions. Key Points
The Tribune India